| Name | trans-Urocanic Acid |
| Description | trans-Urocanic Acid ((E)-Urocanic acid), a compound predominantly distributed in the hippocampus and prefrontal cortex, is an isomer of cis-UCA, an epidermal UV-protectant, which enhances the stability of tenofovir eplerenomide in long-acting HIV applications. trans-Urocanic acid potently modulates immune trans-urocanic acid effectively modulates immune function, inhibits human natural killer cell activity in vitro, and can be used in Alzheimer's disease research. |
| In vitro | In primary human keratinocytes, trans-Urocanic acid (100 μg/mL; 24 hours) reduces cell proliferation and viability[2]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | PBS (pH 7.2) : 0.3 mg/mL (2.17 mM), Sonication is recommended. DMSO : 15 mg/mL (108.6 mM), Sonication is recommended. DMF : 3 mg/mL (21.72 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (14.48 mM), Sonication is recommended.
|
| Keywords | trans-Urocanic Acid | transUrocanic Acid | trans Urocanic Acid |
| Inhibitors Related | Sucrose | Aceglutamide | Emtricitabine | 3-Hydroxybutyric acid sodium | Levulinic acid | D(+)-Raffinose pentahydrate | D-(+)-Trehalose dihydrate | Glycerol | Thymidine | Sodium 2-hydroxybutanoate | Chitosan oligosaccharide | 3-Indoleacetic acid |
| Related Compound Libraries | Bioactive Compound Library | Anti-Alzheimer's Disease Compound Library | Natural Product Library for HTS | Bioactive Compounds Library Max | Gut Microbial Metabolite Library | Human Metabolite Library |